About 12% of claims were denied in 2024, leading to $262 billion in lost revenue to providers. Providers spend about $26 billion annually in recovering denied claims, but only 70%

When James Van Der Beek announced he had been diagnosed with colorectal cancer, it was the kind of news that stunned many of us. I grew up watching Dawson’s Creek,

For those born with a particular type of hearing loss, the main treatment option has been mechanical: an implant that turns sound into electrical signals that stimulate the auditory nerve,

The AI Health Fund launched a new residency program this week called Treehub, which aims to fund early-stage healthcare AI startups coming out of academic labs. The program will run

The way the healthcare industry thinks about interoperability doesn’t capture the whole story.  Interoperability is often described as ensuring that the right participants can access the right patient information at

Merck has FDA approval for a new combination drug for HIV, giving patients a new treatment option and an alternative to a blockbuster Gilead Sciences pill that comes with tolerability

The U.S. Department of Justice is seeing numerous trends of fraud in the Affordable Care Act Marketplace targeting vulnerable populations. At the Medicarians Conference in Las Vegas on Monday, an

Over the past decade or so, I’ve watched on with fascination as consumer wearables have evolved from simple fitness accessories into increasingly sophisticated health tools. Smart rings, watches, patches and

One big news story from the world of Medicare Advantage recently has been the number of plans that are in retrenchment mode. For instance, UnitedHealthcare reportedly exited 109 counties for

Tortugas Neuroscience launched from stealth Tuesday with $106 million to support a pipeline of four in-licensed drugs in clinical development for a range of central nervous system indications. The programs